In mouse models, other checkpoints, such as lymphocyte activation gene 3 (LAG3) and T cell immunoglobulin and mucin domain 3 (TIM3), have been investigated as new targets for CPI treatment. Here, HAVCR2 is linked to isolated cleft palate.